You are invited to join us at our Biopharma Seminars in:
- Leiden on April 4th, Biotech Training Facility
- Groningen on April 5th, NH Groningen
As biotherapeutics become predominant in the pharmaceutical industry, their characterization and quality attributes monitoring has continued to present scientific, technical and business challenges to the youngest or to the more established companies.
Waters demonstrates continuous engagement to deliver purposeful benefits that transforms the way scientists can address these challenges.
This meeting will act as a valuable platform to share knowledge and experiences.
Gain new insight into the latest technology developments and the ability to network with other biopharmaceutical scientists.
Please choose your location to register.
|08:15||Registration and welcome coffee|
|Intact protein and monoclonal antibody (mAb) analysis|
|08:45||Improved separations technologies for Reversed-Phase protein analysis|
|09:15||Fit-for-purpose bio-inert instrumentation for Protein separations:
- HPLC, UHPLC and UPLC technologies
- Quality-by-Design methods development for protein analysis
- Fraction collection
|09:45||Size Exclusion Chromatography and Ion Exchange chromatography|
|10:20||Selecting the right column for peptide and peptide mapping analysis|
|10:35||Glycan analytics: released glycans, glycopeptides and glycoproteins separations|
|10:55||Mass detection for chromatographers:
Benefits and capabilities for amino-acids, peptides, glycans and formulants analysis
|Mass spectrometry for routine analysis|
|11:40||Biopharmaceuticals critical quality attributes:
LC-MS (regulated) solutions for intact mass and peptide mapping based
multiple attribute monitoring
|12:00||Analyzing Proteins Using SEC, MALS, and UPLC
Presentation given by Wyatt Technology
|12:30||Round-table and wrap-up around a lunch
(Lunch offered by Waters)
|13:30||End of the program|
For additional information or questions, please contact us
We are looking forward to meet you!
9713 GW Groningen
Tel.: +31 50 584 8181
|April 4, 2018||Leiden||Details|